Drug Marketing Limits May Be Voided by U.S. Supreme Court

U.S. Supreme Court justices signaled they are poised to overturn a Vermont law that would limit the ability of brand-name drugmakers to target individual doctors with sales pitches.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.